两阶段治疗切换估计的新方法
Dan Jackson1, Di Ran2, Fanni Zhang2
1AstraZeneca, Cambridge, UK.
Pharmaceutical statistics
|February 5, 2025
概括
这项研究引入了分析癌症治疗试验的新方法,患者在这些试验中更换治疗方法. 它有助于更准确地估计治疗效果,即使在常见的治疗转换,帮助医疗保健决策.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验 临床试验
背景情况:
- 在瘤学临床试验中,治疗转换是常见的,这使治疗效果的估计变得复杂.
- 对照组患者经常接受实验性治疗作为后续治疗,这带来了分析挑战.
研究的目的:
- 定义和估计新的治疗效果估计,这些估计可以解释治疗转换的不同比例.
- 通过使用二次基线,为这些新估值调整两阶段估计方法.
- 通过提供可靠的治疗效果估计,促进普遍医疗保健系统的决策.
主要方法:
- 在不同的切换比例下定义了治疗效应的精确估计值.
- 用第一个后续治疗的时间作为二次基线.
- 开发了倾向性评分方法,用于在二次基线上进行混调整.
- 介绍了一种新的量子匹配技术,用于中学后的基线生存模型.
主要成果:
- 拟议的二次基线和估计方法很容易定义和广泛适用.
- 该方法允许估计替代治疗效果的估计值.
- 这种方法的成功动机是现实世界的免疫瘤学试验.
结论:
- 开发的方法提高了在治疗切换的情况下对治疗效应的准确估计.
- 这项工作为医疗保健的决策提供了有价值的工具,特别是在免疫瘤学方面.
- 灵活的估计框架适用于各种中学后基线生存模型.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
131
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
131
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Two-Compartment Open Model: Extravascular Administration
137
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
The absorption exponent (ka) indicates the speed at which the drug...
137
Actuarial Approach
57
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
57
Kaplan-Meier Approach
80
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
80
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
371
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
371


